Lakeridge Health CorporationLakeridge Health Corporation Emergency Medical Directives - 2005 Page 4...

Lakeridge Health Corporation

Emergency Medical Directives - 2005

of 66


Emergency

Medical Directives

MAC Approved:

October 18, 2005

2005



of 66

TABLE OF CONTENTS

GENERAL PREAMBLE: .................................................................................................. 3

ADULT ASTHMA MEDICAL DIRECTIVE (replaced by Nov 2009 directive) ................... 5

ADULT FEVER MANAGEMENT ..................................................................................... 6

ANKLE AND FOOT XRAYS ............................................................................................ 8

CHEST PAIN (ISCHEMIC) MEDICAL DIRECTIVE ....................................................... 11

CONSCIOUS OVERDOSE MEDICAL DIRECTIVE ...................................................... 13

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (replaced by Nov 2009 directive) ....... 16

EMLA CREAM OR PATCH ........................................................................................... 17

FOREARM/ELBOW XRAY ............................................................................................ 19

FRACTURED HIP ......................................................................................................... 21

HAND AND/OR FINGER XRAYS ................................................................................. 23

HYPOGLYCEMIA.......................................................................................................... 25

HYPOTENSIVE VAGINAL BLEEDING ......................................................................... 27

INGESTED FOREIGN BODY ....................................................................................... 29

INSTILLATION OF TOPICAL ANESTHETIC FOR EYE DISCOMFORT ....................... 30

KNEE XRAY .................................................................................................................. 32

TOPICAL LIDOCAINE, EPINEPHRINE, TETRACAINE (LET) ...................................... 35

PEDIATRIC ASTHMA MEDICAL DIRECTIVE (replaced by Nov 2009 directive) .......... 36

PEDIATRIC FEVER MANAGEMENT ............................................................................ 37

PEDIATRIC HYPOGLYCEMIA ..................................................................................... 39

PEDIATRIC SEIZURE (UNDER THE AGE OF 10) ....................................................... 41

PULMONARY EDEMA .................................................................................................. 43

RENAL COLIC .............................................................................................................. 45

SALINE IRRIGATION OF THE TREATMENT OF CHEMICAL EYE BURNS ................ 47

SEIZURE IN PATIENTS OVER THE AGE OF 10 YEARS ............................................ 49

TETANUS/DIPTHERIA/PERTUSSIS IMMUNIZATION ................................................. 50

URINE SAMPLING........................................................................................................ 52

URINARY CATHETERIZATION .................................................................................... 53

WRIST AND SCAPHOID X-RAYS ................................................................................ 55

LIST OF AUTHORIZING PHYSICIANS: LAKERIDGE HEALTH OSHAWA .................. 57

LIST OF AUTHORIZING PHYSICIANS: LAKERIDGE HEALTH BOWMANVILLE ........ 58

LIST OF AUTHORIZING PHYSICIANS: LAKERIDGE HEALTH PORT PERRY ........... 59

SIGNATURE LIST OF COMMITTEE AND PROGRAM APPROVALS (Chairs) ............ 60

REVIEW AND APPROVAL TRACKING FORM ................................................................... 61

APPENDIX 1 REFERENCES ........................................................................................ 62



of 66

GENERAL PREAMBLE: These Medical Directives are applicable to the Lakeridge Health Corporation Emergency Departments at the Bowmanville, Oshawa and Port Perry Sites. The Authorizing Physicians are the practicing Emergency Physicians at the 3 hospital sites as outlined in the Authorizing Physicians Section of the preamble. These Authorizing Physicians will be authorizing all the medical directives outlined in this document. The directives are not applicable to Consulting Physicians or Family Physicians seeing their own patients directly in one of the Emergency Departments unless that Physician is a listed signatory to this document. “Appropriately Educated” Health professionals will refer to those employees of Lakeridge Health who have successfully attained certification by a course of self study supplied by the Clinical Education leader of the Emergency Program and successfully passed a written examination. The content of the Educational package will be approved by the Corporate Emergency Council. The Authorizing Physicians expect that only appropriately educated Health Care Practitioners; who are employees of Lakeridge Health Corporation: with the specific professional qualifications as outlined in each medical directive will implement these medical directives. The Authorizing Physicians also expect that the Health Care Practitioners performing the medical directives will adhere to the specific clinical conditions/circumstances and contraindications. Deviation from these medical directives is not authorized by the Emergency Physicians. The Authorizing Physicians expect that Lakeridge Health Corporation will provide the initial and ongoing education and ongoing continuous quality improvement of these medical directives as directed by the Emergency program. It is expected that all staff authorized to perform a medical directive will obtain and document appropriate informed consent prior to carrying out the medical directive. Documentation of the use of a Medical Directive will be made with a notation in the space provided on the Emergency Department Health Record and a copy of the specific Medical Directive will be attached to the permanent Emergency Department Health Record.



of 66

This will apply to the 2005 Emergency Department Directives listed: Adult Asthma Adult Fever Management Ankle & Foot X-rays Chest (Ischemic) Pain Conscious Overdose COPD Emla Cream Patch Forearm Elbow X-rays Fractured Hip Hand or Finger X-ray Hypoglycemia Hypotensive Vaginal Bleeding Ingested Foreign Body Instillation of topical Anesthetic for Eye discomfort Knee X-ray LET Pediatric Asthma Pediatric Fever Pediatric Hypoglycemia Pediatric Seizure Pulmonary Edema Renal Colic Saline irrigation of the eye Seizure Tetanus Diptheria Pertussis Immunization Urinalysis Urinary Catheterization Wrist & Scaphoid X-ray



of 66

NOTE: Please see revised “Adult Asthma” Medical Directive, approved Nov 10, 2009, posted separately on the WAVE in Medical Directives>Emergency folder.

Adult Asthma (LHC) revised Nov 10, 2009

ADULT ASTHMA MEDICAL DIRECTIVE

Previous version of this medical directive approved by MAC Oct 2005 Has been ARCHIVED

http://172.16.17.81/Intranet/documents/Medical%20Directives%20Delegated%20controlled%20Acts/EMERGENCY/19552/Adult%20Asthma%20(LHC)~~000010001.pdf



of 66

ADULT FEVER MANAGEMENT MEDICAL DIRECTIVE

Authorized to who: An appropriately educated Registered Nurse in the Emergency Department may initiate the following therapies for patients who present with a documented febrile episode. Medical Directive Description: Adults may be given Acetaminophen 650 mg per os or per rectum prn for temperature >38 Celsius x 1 dose OR One dose of Ibuprofen 400 mg PO The temperature should be reassessed 30 minutes after administration of medication. Patient Description/Population:

Adults with a temperature > 38 celsius

The patient should be alert and have an intact gag reflex for use of oral medications

Vital signs assessment prior to administration

History of antipyretic therapy (adequacy of dose, response) must be documented. If a sub-therapeutic dose has been given, calculate the difference between the inadequate dose and the therapeutic dose and administer that amount.

Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

Adults must have a temperature > 38 Celsius

The patient must be greater than 12 years of age, have a patent airway, an intact gag reflex

Each intervention will be explained to the patient and/or family and verbal consent will be obtained.

Patient must be conscious Contraindications to the implementation of the Directive:

Lack of patient/family consent

All pregnant patients must be assessed by a physician prior to implementing medication components of the directive.

Allergy to acetaminophen or ibuprofen

History of cirrhosis, chronic liver disease or alcoholism

Recent anti-pyretic administration (<3 hours)



of 66

Documentation requirements:

Implementation of the Medical Directive must be documented on the ER chart under physician orders

Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.

There is a space on the chart to indicate the use of a Medical Directive.



of 66

ANKLE AND FOOT XRAYS MEDICAL DIRECTIVE

Authorized to who: Appropriated educated Registered Nurses who work in the Emergency Department may initiate the following therapies for any adult patients who present with possible symptoms of a fractured ankle or foot. Bony tenderness or inability to weight bear must be established according to Ottawa Ankle Rules. Medical Directive Description:

Establish baseline vital signs (B/P, P, R, O2 Sat) as indicated

Patient to remain NPO until examination with Emergency Physician has been achieved

Establish history of trauma or significant injury – document

Document date of LMP on females of child bearing years – if pregnancy is suspect document in order entry screen

An Ice pack or cold compress is to be applied to injuries less than 8 hours old

Assess patient according to the Ottawa Ankle Rules - X-ray ankle and/or foot as indicated by examination

Patient Description/Population: Patient must present with pain suggestive of a fractured ankle or foot on initial assessment by nurse. Affected leg may be swollen and painful on examination. A history of significant injury or trauma must be present.

Patient must be 18 years of age or older and not pregnant. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:




of 66

Contraindications to the implementation of the Directive:

Lack of patient consent

All pregnant patients must be assessed by a physician prior to implementing x-ray

Intoxicated patients are excluded

Patients with multiple painful injuries are excluded

Patients with head injuries are excluded

Patients with diminished sensation due to a neurological deficit are excluded (eg. CVA, Unconscious)







of 66

Figure 1 Ottawa Ankle Rule



of 66

CHEST PAIN (ISCHEMIC) MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following for adult patients arriving to the Emergency Department with chest pain suggestive of cardiac ischemic pain. Medical Directive Description:

12 Lead EKG - notify physician immediately if ST elevation, ST segment depression or new onset LBBB

obtain additional leads; 15 lead ECG, if inferior or posterior myocardial infarction suspect.

Request old charts and old ECG’s

Initiation of Normal Saline (N/S) IV at 30 mL/hr (tkvo)

O2 to keep oxygen saturation above 95%

CCU blood work

Portable Chest X-ray if available on site

Nitroglycerin 0.4 mg spray sublingually every five minutes until pain is relieved or a maximum of three doses have been administered

Acetylsalicylic Acid (ASA) 160 mg chewed if no ASA in last 24 hours

Morphine 2.5 - 5 mg IV increments (if Nitrospray is ineffective) titrate until pain is relieved or a maximum of 20 mg has been given

Dimenhydrinate (Gravol) 25-50 mg IV prn for one dose

Administer a fluid bolus of 250 mL Normal Saline if BP <90 mm Hg in the absence of any signs of respiratory distress

Patient Description/Population Patient must present with chest pain suggestive of an acute coronary syndrome on initial assessment by nurse. Identify relevant Delegated Control Act or Added Skill associated with this Directive: IV Insertion certification. Specific conditions/circumstances that must be met before the Directive can be implemented:

The patient must have Chest pain suggestive of Cardiac Ischemia on initial assessment by the Zone Nurse

Explanation of each of the above procedures must be provided to the patient.

The patient must verbally consent to each of these procedures

Include the doses of Nitroglycerin and Morphine given by Paramedics (in the prehospital care of the patient) in the calculation of maximal doses

All female patients of childbearing age must be assessed to rule out pregnancy prior to performing chest x-ray.

IV access must be established prior to administration of Nitroglycerin.



of 66


Lack of patient consent.

Blood Pressure must be checked after each Nitroglycerin and Morphine increment and medication is to be held if BP< 90 systolic

Nitroglycerin and Morphine are to be held if HR<40 or >140

ASA is to be held if a history of bleeding Peptic Ulcer, NSAID induced Gastritis Or a history of ASA precipitated Asthma

Prior to ordering x-rays, the Physician should assess a woman who suspects she might be or is pregnant.

Allergies to ASA, Morphine, Nitroglycerin or Dimenhydrinate will preclude administration of that drug.

If patient has a history of erectile dysfunction medication use within 24 hours ie. sildenafil (Viagra) or tadalafil (Cialis) or vardenafil (Levitra) then hold Nitroglycerin and report ingestion to physician.

Hold ASA dose if it has been administered in the Pre-hospital phase by Paramedics

Hold Nitrates if a right ventricular infarct is suspected on 15-lead ECG Documentation requirements:






of 66

CONSCIOUS OVERDOSE MEDICAL DIRECTIVE Authorized to who: Appropriately educated Registered Nurses working in the Emergency may initiate the following for a conscious patient with intact gag reflex if the ingestion has occurred within the last 1 hour: Medical Directive Description:

Activated Charcoal 1 gm/Kg per os All children will have an accurate weight recorded and dose will be weight based Adults who cannot be weighed will be given a 50 Gm dose initially. Contact Poison Control Print out the toxicology information from Micromedex (PoisonIndex) on Emergency Department computer.

Poison Control HSC 1-800-268-9017 or 1-416-813-5900 Ottawa Poison Control (CHEO) 1-800-267-1373 Canutec HazMat Information 1-613-996-6666

Patient Description/Population: The patient must have a history of ingestion of a quantity of medication or noxious material deemed appropriate for treatment with activated charcoal by a provincial poison advice centre. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented: The patient must have a patent airway, an intact gag reflex. Contraindications to the implementation of the Directive: Lack of patient/family consent All pregnant patients must be assessed by a physician prior to implementing medication components of the directive. Patient must be conscious. Patients who are somnolent, have reduced LOC or are obtunded must not be given activated charcoal per os Patients with recent abdominal surgery, trauma or suspected obstruction Documentation requirements:


Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council



of 66

Related Documents: LHC POISON CENTRE COMMUNICATION RECORD Appendix 1 References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

LAKERIDGE HEALTH CORPORATION Name: Unique #: POISON CENTRE COMMUNICATION RECORD H.C.#: Physician: If possible complete the first section of the form before call the Poison Centre in: TORONTO 1-800-268-9017 OTTAWA 1-800-267-1373

AGE SEX WT/KG TIME SINCE

INGESTION

BLOOD PRESSURE

PULSE RESP TEMP

SUBSTANCE OR PRODUCT NAME AMOUNT ROUTE OR AREA CONTAMINATED

1.

2.

3.

SYMPTOMS: none headache drowsy hyperactivity tachycardia nausea coma coughing convulsions bradycardia vomiting vertigo dyspnea eye irritation dysrhythmias diarrhea ataxia resp. dep. skin irritation oral irritation cyanosis hallucinations other/specify: ADVICE RECEIVED FROM H.S.C. – TIME:________ FROM WHOM:_______________ oral fluids___________________ activated charcoal_________________________ IV fluids ____________________ cathartic________________________________ eye irrigation_________________ cardiac monitor___________________________ skin irrigation ________________ lab work________________________________ Ipecac_______________________ gastric lavage____________________________ x-ray________________________ other/specify_____________________________ _____________________________________________________________________________________________ Signs and symptoms of toxicity:____________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________ Date____________________SIGNATURE:_________________________________RN



of 66

Note: Please see revised COPD medical directive, approved Nov 10, 2009, posted separately on the WAVE.

COPD (LHC) revised Nov 10, 2009

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

MEDICAL DIRECTIVE Previous version of this medical directive approved by MAC Oct 2005

Has been ARCHIVED

http://172.16.17.81/Intranet/documents/Medical%20Directives%20Delegated%20controlled%20Acts/EMERGENCY/19553/COPD%20(LHC)~~000010001.pdf



of 66

EMLA CREAM OR PATCH MEDICAL DIRECTIVE

Authorized to who: An appropriately educated Registered Nurse in the Emergency Department. Medical Directive Description: A Registered Nurse working in the Emergency Department may apply EMLA topical anesthetic to reduce the pain or anxiety of venipuncture or procedures. Patient Description/Population:

Patient must be >6 months age.

In adults reserve for patient's with extreme anxieties to interventions.

Contact with skin is at least 60 minutes.

Use 1 – 2 patches or apply 2.5g (prilocaine 2.5% and lidocaine 2.5%) thickly covering the area and apply an occlusive dressing.

EMLA may be left on 4-5 hours without risks. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

The Nurse doing the procedure should look for optimal site preference & note the time it is applied on the site

Guardian or patient consent

Guardian presence to ensure supervision of safety instructions with EMLA as per policy.

Intact skin

Stable non-emergent patients

No more than 2 patches may be applied at the same time

Contact with skin is at least 60 minutes

Use 1-2 patches or apply 2.5g (prilocaine 2.5% & lidocaine 2.5%) thickly covering the area and apply an occlusive dressing

EMLA may be left on 4-5 hours without risks Contraindications to the implementation of the Directive:

Not for use around genitals, mouth, or eyes (mucous membranes)

Not for use in emergent situations where time is essential

Hypersensitivity to lidocaine, prilocaine or other anesthetics of the Amide type

Nonintact skin

PMH of methemoglobinemia



of 66



Response to medications administered must be documented Review/Evaluation Process (how often/by who): every two years by Corporate ER Council Related Documents: References: Refer to appendix 1.

The use of this Medical Directive must be documented on the Emergency Chart.




of 66

FOREARM/ELBOW XRAY MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses who have worked in the Emergency Department may initiate the following therapies for any adult patients who present with symptoms of a fractured forearm. Bony tenderness or inability to use the affected part must be established. Medical Directive Description:






Assess patient to establish tenderness and/or displacement of radius or ulna - X-ray forearm as indicated by examination

Assess for scaphoid tenderness and if positive go to the Scaphoid Xray medical directive

Apply splint as needed to stabilize the affected part Patient Description/Population: Patient must present with pain suggestive of a fractured forearm on initial assessment by nurse. Affected arm may be swollen and painful on examination. A history of significant injury or trauma must be present.

Patient must be 18 years of age or older and not pregnant. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented: Each intervention will be explained to the patient and/or family and verbal consent will be obtained. Contraindications to the implementation of the Directive:









of 66



Review/Evaluation Process (how often/by who): every two years by Corporate ER Council Related Documents: References: Refer to appendix 1





of 66

FRACTURED HIP MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses who are working in the Emergency Department may initiate the following therapies for any adult patients who present with symptoms of a fractured hip. Medical Directive Description:

Hip Fractures: AVOID internal/external rotation, flexion & adduction of affected limb.

Establish initial vital signs (B/P, P, R, O2 Sat)

Establish IV N/S TKVO (30 mL/hr)

Insert foley catheter and monitor urine output

Oxygen therapy per nasal prongs prn ( target Oxygen saturation >92%)

Patient to remain NPO until consultation with Orthopedic Surgeon has been achieved – if no transfer possible may offer patient full fluid diet - Reassess q shift for opportunity to increase diet.

CBC, Lytes, Creatinine, aPTT, INR, Albumin, Urinalysis, BhCG (females between 12-55 years of childbearing potential)

ECG

CXR , X-ray pelvis and affected hip

Morphine 2.5- 5 mg IV prn titrate to relieve pain or until a maximum of 20 mg has been given

Dimenhydrinate 25 mg IV prn nausea or vomiting x 1 dose

Patient Description/Population: Patient must present with pain suggestive of a fractured hip on initial assessment by nurse. Affected leg may be shortened or externally rotated on examination.

Patient must be 18 years of age or older and not pregnant. Identify relevant Delegated Control Act or Added Skill associated with this Directive: IV insertion certification. Specific conditions/circumstances that must be met before the Directive can be implemented:

IV access must be established prior to administration of Morphine

Vital signs pre & post administration of Morphine – consult physician if systolic BP< 90 mm Hg or pulse/heart rate < 40 bpm


Medications given by prehospital personnel or taken by patient just prior to arrival must be included in the calculation of maximum doses of Morphine.



of 66



All pregnant patients must be assessed by a physician prior to implementing x-ray and medication components of the directive.

Allergy to Morphine or Dimenhydrinate will preclude administration of that drug. Documentation requirements:


Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years by Corporate Er Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart. There is a space on the chart to indicate the use of a Medical Directive.



of 66

HAND AND/OR FINGER XRAYS MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses who are working in the Emergency Department may initiate the following therapies for any adult patients who present with symptoms of a fractured hand or finger. Bony tenderness or inability to use affected part must be established. Medical Directive Description:






Assess patient for tenderness and/or obvious displacement/deformity of metacarpal bones, MCP joints and phalanges.

Assess for scaphoid tenderness, if positive go to the scaphoid Xray medical directive Patient Description/Population: Patient must present with pain suggestive of a fractured hand or finger on initial assessment by nurse. Affected hand may be swollen and painful on examination. A history of significant injury or trauma must be present Patient must be 18 years of age or older and not pregnant. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:











of 66



Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

HYPOGLYCEMIA MEDICAL DIRECTIVE

Authorized to: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following therapies for patients who present with symptoms or signs of hypoglycemia.

Medical Directive Description: Blood sugar result of < 4 mmol/L and patient remains conscious with an intact gag reflex – supply the patient with 15 g of carbohydrate or equivalent as outlined in table 1.

Table 1. Examples of 15 g of carbohydrate for the treatment of mild to moderate hypoglycemia - Canadian Diabetes Association 2003 Clinical Practice Guidelines

15 g of glucose in the form of glucose tablets

15 mL (3 teaspoons) or 3 packets of table sugar dissolved in water

175 mL (3/4 cup) of juice or regular soft drink

6 Life Savers (1=2.5 g of carbohydrate)

15 mL (1 tablespoon) of honey

avoid orange juice in renal patients because of potassium (K) content and replace with apple or cranberry juice with granulated sugar added

If blood sugar of < 4 mmol/L and patient has a change in mental status such that he/she cannot tolerate oral intake then: Keep NPO and attempt IV of D5W (5% Dextrose in water solution) TKVO at 30 mL/hr Administer 50 mL of pre-packaged 50% Dextrose solution IV

If unable to administer IV or if the patient is combative: Glucagon 1 mg may be administered IM or SC Patient Description/Population: Patients who present with symptoms suggestive of hypoglycemia 12 years of age and over Identify relevant Delegated Control Act or Added Skill associated with this Directive:



of 66

Specific conditions/circumstances that must be met before the Directive can be implemented: The patient must appear to be hypoglycemic (pale, shaking, diaphoretic, headache, tremors, confusion). There may be an established history of diabetes and use of oral hypoglycemic agents or insulin injections. Certification in the use of Point of Care Glucometer testing IV Certification Contraindications to the implementation of the Directive:

Established allergy to Glucagon

Avoid orange juice in Renal Patients (relatively high potassium content)

Refusal of patient/family consent for treatment – notify Dr immediately Documentation requirements


Response to medications administered must be documented Review/Evaluation Process: every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1





of 66

HYPOTENSIVE VAGINAL BLEEDING MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department. Medical Directive Description: Initiate the following for adult patients arriving to the Emergency Department with vaginal bleeding and hypotension (Systolic BP<90):

Initiation of large bore Normal Saline IV and start 500 mL bolus

O2 to keep oxygen saturation above 95%

CBC, Type and Screen

Urine for beta-HCG

Draw blood for Quantitative beta-HCG and send to the lab if urine beta-HCG positive

Insert Foley Catheter prn

Bring ER portable Ultrasound to bedside if available Patient Description/Population: The patient must be over 13 years of age and capable of consenting to the procedures and treatment. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented: The patient must have Vaginal Bleeding and a systolic blood pressure <90 mmHg on initial assessment by the Nurse Explanation of each of the above procedures must be provided to the patient. Contraindications to the implementation of the Directive: Lack of patient consent. Documentation requirements:




of 66





of 66

INGESTED FOREIGN BODY MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department. Medical Directive Description: Registered Nurses in the Emergency Department may order a flat plate x-ray of the abdomen and chest. Patient Description/Population: The patient can be any age. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

Patient presents with a history of ingestion of a foreign body.

Women of childbearing age must be asked if they are pregnant. If a woman suspects she may be pregnant a urine pregnancy test must be completed and negative prior to having x-rays.


Confirmed pregnancy.

Any respiratory distress

Lack of consent Documentation requirements:


Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References:





of 66

INSTILLATION OF TOPICAL ANESTHETIC FOR EYE DISCOMFORT MEDICAL DIRECTIVE

Authorized to who: An appropriately educated Registered Nurse in the Emergency Department. Medical Directive Description: Prior to the Emergency Physician assessing the patient, a Registered Nurse, in the Emergency Department may:

Instill 1-2 drops Proparacaine HCL 0.5% or Tetracaine 0.5% topical anesthetic in the affected eye(s) for comfort while awaiting Physician Assessment to facilitate Visual Acuity testing by the Registered Nurse.

This can be repeated q 10-15 minutes prn x 4 doses. Patient Description/Population: Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

The patient has eye discomfort due to an abrasion or foreign body

The Patient or Guardian must be able to provide informed consent

Patient must be able to cooperate in the performance of the procedure Contraindications to the implementation of the Directive:

Perforation of the globe

Hypersensitivity to the Topical Anesthetic or related local anesthetics

Malignant hyperthermia Documentation requirements:


Response to medications administered must be documented

Vital signs pre and q15 to 30 minutes post pain medication Review/Evaluation Process (how often/by who): every two years Corporate ER Council Related Documents:



of 66

References:

Refer to appendix 1





of 66

KNEE XRAY MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses who are working in the Emergency Department may initiate the following therapies for any adult patients who present with symptoms of a knee injury. Bony tenderness or inability to weight bear must be established according to Ottawa Knee Rules. Medical Directive Description:






Assess patient according to the Ottawa Knee Rules - X-ray knee if indicated by examination

Patient Description/Population: Patient must present with pain suggestive of a fracture, ligamentous or meniscal injury on initial assessment by nurse. Affected leg may be swollen and painful on examination. A history of significant injury or trauma must be present. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

Each intervention will be explained to the patient and/or family and verbal consent will be obtained. Contraindications to the implementation of the Directive:











of 66





of 66

TOPICAL LIDOCAINE, EPINEPHRINE, TETRACAINE (LET) MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following directive. Medical Directive Description:

may apply LET topical anesthetic to simple lacerations.

Apply 3 mL of the LET solution on a cotton ball and apply to non intact skin

Apply for 25-30 minutes and note the time on the ED chart. Patient Description/Population: Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

For use on simple lacerations not involving the mucous membranes or peripheral extremities or sign of injury to underlying structures

Tape must not be used on hair bearing areas

On the scalp have the parent or patient put on a glove, apply a small amount of Vaseline to the surrounding hair, and have the cotton ball soaked with LET firmly held in place by the patient or parent

Parental or Guardian consent and supervision for safety instructions as per policy (Do not let it run into eyes, mouth, ears, or nose)


Lack of patient or guardian consent

Complicated lacerations

Lacerations involving mucous membranes or peripheral extremities (digits)

Hypersensitivity to Lidocaine, Epinephrine, Tetracaine or Metabisulfite Documentation requirements:


Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1

The use of this Medical Directive must be documented on the Emergency Chart. There is a space on the chart to indicate the use of a Medical Directive.



of 66

Note: Please see revised Pediatric Asthma Medical Directive, approved Nov 10 2009, posted separately on the WAVE.

Paediatric Asthma (LHC) - revised Nov 10, 2009

PEDIATRIC ASTHMA MEDICAL DIRECTIVE

Previous version of this medical directive approved by MAC Oct 2005 Has been ARCHIVED

http://172.16.17.81/Intranet/documents/Medical%20Directives%20Delegated%20controlled%20Acts/EMERGENCY/19554/Paediatric%20Asthma%20(LHC)~~000010001.pdf



of 66

PEDIATRIC FEVER MANAGEMENT MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department. may initiate the following therapies for patients who present with a documented febrile episode. Medical Directive Description: Give an anti-pyretic to children with a temperature > 38 Celsius The temperature should be reassessed 30 minutes after administration of medication Either: One dose of Acetaminophen based on weight calculated as 15 mg/kg PO/PR (maximum dose 650 mg)

Wk kg Age Group Single/Dose (mg) 6-7.9 6-11months 80 8-10.9 12-23 months 120

11-15.9 2-3 years 160 16-21.9 4-5 years 240 22-26.9 6-8 years 320 27-31.9 9-10 years 400 32-43.9 11 years 480 OR One dose of Ibuprofen 5-10 mg/kg PO Motrin Dosing for Children Under 12 Years

Wk kg Age Group Single/Dose (mg) 6-7.9 6-11months 50 8-10.9 12-23 months 75

11-15.9 2-3 years 100 16-21.9 4-5 years 150 22-26.9 6-8 years 200 27-31.9 9-10 years 250 32-43.9 11 years 300 Patient Description/Population:

Children (3 months – 12 years) with a temperature >38 Celsius

For use of oral meds, the patient should be alert and have an intact gag reflex for use of oral medications

An accurate weight must be documented on the chart

Vital signs including capillary refill assessment prior to administration

History of antipyretic therapy (adequacy of dose, response) must be documented. If a sub-therapeutic dose has been given, calculate the difference between the inadequate dose and the therapeutic dose and administer that amount.



of 66

Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

Child must have a temperature >38 Celsius

The patient must be greater than 3 months of age, have a patent airway, an intact gag reflex and active bowel sounds on auscultation.

Each intervention will be explained to the patient and/or family and verbal consent will be obtained

Patient must be conscious Contraindications to the implementation of the Directive:

Age less than 3 months with pyrexia – notify ER Dr stat


Allergy to acetaminophen or ibuprofen

History of cirrhosis, chronic liver disease

Recent acetaminophen administration (<3 hours) or > 5 doses of acetaminophen in previous 24 hour period (>65 mg/kg).


Implementation of the Medical Directive must be documented on the ER chart under physician orders.

Response to medications administered must be documented Review/Evaluation Process (how often/by who): every two years by Corporate ER Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

PEDIATRIC HYPOGLYCEMIA MEDICAL DIRECTIVE

Authorized to: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following therapies for patients who present with signs or symptoms of hypoglycemia.

Medical Directive Description: Blood sugar result of < 4 mmol/L and patient remains conscious with an intact gag reflex – supply the patient with 10 g of carbohydrate or equivalent as outlined in table 1 Table 1. Examples of 10 g of carbohydrate for the treatment of mild to moderate hypoglycemia - Canadian Diabetes Association 2003 Clinical Practice Guidelines

10 g of glucose in the form of glucose tablets

10 mL (2 teaspoons) or 2 packets of table sugar dissolved in

water

100 mL (1/2 cup) of juice or regular soft drink

4 Life Savers (1=2.5 g of carbohydrate)

10 mL (2 teaspoons) of honey

If blood sugar of < 4 mmol/L and patient has a change in mental status (i.e. GCS<14 or unable to cooperate such that he/she cannot tolerate oral intake) then:

Establish an IV D5W tkvo at 30 mL/hr

Keep NPO and administer 0.5 g/kg (2 mL/kg) 25% DEXTROSE IN WATER, IV slowly, to maximum of 12.5g (50mL).(Prepare the D25W solution by wasting 25 mL of a D50W preload and then drawing up 25 mL Sterile water or Normal Saline into the syringe).

If unable to administer IV or if the patient is combative: Glucagon 1 mg sc may be administered IM or SC (Wt > 20 kg) Glucagon 0.5 mg sc may be administered IM or SC (Wt < 20 kg) Patient Description/Population: Patients who present with symptoms suggestive of hypoglycemia under the age of 12 Identify relevant Delegated Control Act or Added Skill associated with this Directive:



of 66

Specific conditions/circumstances that must be met before the Directive can be implemented: The patient must appear to be hypoglycemic (pale, shaking, diaphoretic, headache, tremors, confusion). There may be an established history of diabetes and use of oral hypoglycemic agents or insulin injections. Certification in the use of Point of Care Glucometer testing IV Certification Contraindications to the implementation of the Directive:

Established allergy to Glucagon

Refusal of patient/family consent for treatment – notify Dr immediately Documentation requirements


Response to medications administered must be documented Review/Evaluation Process: every 2 years Corporate ER Council Related Documents: Hypoglycemia Medical Directive References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

PEDIATRIC SEIZURE (UNDER THE AGE OF 10) MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department initiate the following for a pediatric patient who is an active seizure state in the ER: Medical Directive Description:

Ensure airway is patent

Administer oxygen therapy at 100% by mask to maintain saturation above 94%

Place patient in the recovery position to prevent aspiration and injury.

Estimate child’s weight based on Broselow tape measurement or the following formula Estimated Wt = 2 x age + 8 (kg)

Administer Midazolam 0.2 mg/kg IM

If an IV is established prior to IM drug administration or Seizure has not abated then attempt to establish an IV of Normal Saline to run at 10-15 mL/hr

Monitor vital signs q5-10min and ECG continuously

Administer Midazolam 0.1 mg/kg IV or alternatively lorazepam 0.05 mg/kg IV (to a maximum dose of 1 mg of lorazepam)

If the seizure does not abate within five minutes administer a 2nd dose of the chosen drug at ½ the previous dose by the same route

Test Blood sugar and if <4mmol/l refer to paediatric hypoglycemia directive

Obtain a baseline set of vital signs including a temperature

If temperature is >38.0 degrees centigrade administer acetaminophen 15 mg/kg per rectum to a maximum of 650 mg

Patient Description/Population: The patient must be exhibiting active seizure activity Patient must be under the age of ten Identify relevant Delegated Control Act or Added Skill associated with this Directive: IV Insertion Certificate Specific conditions/circumstances that must be met before the Directive can be implemented: The patient must present with active tonic clonic seizure activity and have a patent airway Contraindications to the implementation of the Directive:


Allergy to lorazepam or midazolam



of 66



Response to medications administered must be documented Review/Evaluation Process (how often/by who): every two years by Corporate ER Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

PULMONARY EDEMA MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following therapies for patients who present with symptoms suggestive of acute pulmonary edema. Medical Directive Description:

Administer oxygen therapy by mask to maintain saturation above 92%

Position patient in Semi to high Fowlers to facilitate chest expansion if tolerated by patient and systolic BP > 90 mm

12 Lead EKG - notify physician immediately if ST elevation, ST segment depression or new onset LBBB

obtain additional leads; 15 lead ECG, if inferior or posterior myocardial infarction suspect.

Initiated IV N/S at 30 mL/hr TKVO

Monitor vital signs q5-10min and cardiac rhythm continuously

Chest x-ray

Insert foley catheter and monitor urine output hourly

Nitroglycerin 0.4 mg spray titrated to BP as follows o If the SBP > 140 mmHg, administer 0.8 mg NTG (2 stacked sprays) SL,

q5 min to a maximum of 8 administrations. o If SBP 100 mmHg -140 mmHg, administer 0.4 mg NTG SL, q5 min to a

maximum of 8 administrations. o BP<100 systolic hold

Enalaprilat 1.25 mg IV or Captopril 12.5 mg po x 1 dose after review with MD

Dimenhydrinate 25-50 mg IV q1hr prn nausea & vomiting

Furosemide 40 mg IV or double the patient’s usual oral dose to a maximum of 80 mg and administer IV

Obtain charts of previous visits. Patient Description/Population: Patients who present with symptoms suggestive of acute pulmonary edema. The patient must have shortness of breath and symptoms suggestive of Pulmonary Edema (dyspnea, tachypnea, orthopnea, crackles throughout the lung fields). The patient may expectorate pink, frothy sputum. Identify relevant Delegated Control Act or Added Skill associated with this Directive: IV Insertion Certificate



of 66

Specific conditions/circumstances that must be met before the Directive can be implemented:

The patient must have shortness of breath and symptoms suggestive of Pulmonary Edema (dyspnea, tachypnea, orthopnea, crackles throughout the lung fields). The patient may expectorate pink, frothy sputum.


Medications given by pre-hospital personnel or taken by patient just prior to arrival must be included in the calculation of maximum doses of ASA and Nitroglycerin

IV access must be established prior to administration of Nitro spray

Vital signs pre & post administration of Nitro, Furosemide ,Enalapril and Captoril – consult physician if systolic BP< 90 mm Hg or pulse/heart rate < 40



All pregnant patients must be assessed by a physician prior to implementing x-ray and medication components of the directive.

Allergy to ASA, Morphine, Nitroglycerin or Dimenhydrinate will preclude administration of that drug.

If patient has history of erectile dysfunction medication use within 24 hours ie. sildenafil (Viagra) or tadalafil (Cialis) or vardenafil (Levitra) then hold Nitroglycerin and report ingestion to physician.

Hold ASA if Hx of recent GI bleed or peptic ulcer disease Documentation requirements:



Vital signs pre & post administration of Nitroglycerin and Furosemide Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1





of 66

RENAL COLIC MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following for patients who present to the ER with symptoms indicative of renal colic and who are exhibiting significant distress. Medical Directive Description:

Urine test when able to void – test for blood, rule out pregnancy with Beta HCG

Monitor vital signs q15min

Administer (Non parenteral option) Ketorolac 10 mg P.O. may repeat x 1 after 30 minutes

Metochlopramide 10 mg P.O. Indocid 50 mg suppository P.R.

If patient unable to tolerate oral medications due to nausea and vomiting: IM Option:

Ketorolac 30 mg IM

Metochlopramide 10 mg IM IV Option:

o Establish IV Normal Saline at 30 mL/hr o Patient to remain NPO o Administer Ketorolac 30 mg IV q20min x 2 doses or Morphine 5 mg IV

increments titrate for pain relief to a maximum of 20 mg o Dimenhydrinate 25-50 mg IV prn nausea or vomiting x 1 dose

Patient Description/Population: Patients who present to the ER with symptoms indicative of renal colic and who are exhibiting significant distress. Identify relevant Delegated Control Act or Added Skill associated with this Directive: IV Insertion Certification Specific conditions/circumstances that must be met before the Directive can be implemented:


Patient must be 18 years of age or older



of 66


Allergy to Morphine, Ketorolac, Metochlopramide or Dimenhydrinate will preclude use of that medication


All pregnant patients must be assessed by physician prior to implementing x-ray and medication components of the directive.

Caution with IVP if patient taking oral hypoglycemic agents

Hold Ketorolac / Indomethacin: if patient has a history of GI distress/bleed, peptic ulcer disease, a history of renal disease, liver disease or congestive heart failure




Vital signs pre and q15 to 30 minutes post pain medication Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

SALINE IRRIGATION OF THE TREATMENT OF CHEMICAL EYE BURNS IN THE EMERGENCY DEPARTMENT

MEDICAL DIRECTIVE Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department. Medical Directive Description: Prior to the Emergency Physician assessing the patient, a Registered Nurse, in the Emergency Department may:

Test pH of affected eye in cases of Alkali burns and if pH>8 after irrigation then irrigate a second time for an additional 20-30 minutes

Retest pH after 30 minutes

Instill 1-2 drops Proparacaine HCL 0.5% or Tetracaine 0.5% topical anesthetic in the affected eye(s) for comfort

Place the Morgan Lens as per protocol Patient Description/Population: Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

The patient has had an accidental chemical splash into one or both eyes

The Patient or Guardian must be able to provide informed consent

Patient must be able to cooperate in the performance of the procedure Contraindications to the implementation of the Directive:

Perforation of the globe

Other associated life threatening injuries

Hypersensitivity to topical anesthetic or related local anesthetics Documentation requirements:


Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents:



of 66

References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

SEIZURE IN PATIENTS OVER THE AGE OF 10 YEARS MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following for patients actively seizuring in the Emergency Department. Medical Directive Description:

Ensure airway is patent and supply Oxygen 100%

Place the patient in recovery position

Initiate an IV of Normal Saline at 30 mL/hr

Administer diazepam 5 mg IV given slowly over 1 minute or per rectum initially, then 2.5 mg increments every 15-30 seconds up to a maximum of 10 mg or until the seizure abates.

Test blood sugar if <4 mmol/L administer 50 mL 50% Dextrose IV Patient Description/Population: Patients 10 year of age or older Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented:

The patient presents with an active tonic clonic seizure in the Emergency Department.


Allergy to diazepam.



Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1





of 66

TETANUS/DIPTHERIA/PERTUSSIS IMMUNIZATION MEDICAL DIRECTIVE

Authorized to who: An appropriately educated Registered Nurse in the Emergency Department. Medical Directive Description: Prior to the Emergency Physician assessing the patient, a Registered Nurse, in the Emergency Department may:

Administer 0.5 mL tetanus diphtheria (Td) IM to eligible patients

Administer 0.5 mL Adacel (DTaP “tetanus diphtheria acellular pertussis) IM to 14-16 year old patients who require immunization instead of Td

Determine if primary series of injections were ever given (if not patient will need to follow up with their Family Physician or Public Health for immunizations in 1 month and 6 months time)

Patient Description/Population: The patient is over the age of 7 and the patient has sustained a laceration, abrasion, burn, bite or foreign body injury. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented: The Patient or Guardian must be able to provide informed consent. The patient has not had a Td immunization within 10 years or the patient's Td booster status is unknown Contraindications to the implementation of the Directive: Tetanus prone wounds (ie. Wounds contaminated by bites, with soil, feces or severe crush injuries allowing for anaerobic conditions) notify the Physician who will assess and decide on the use of tetanus immune globulin if >5 years since last immunization Lack of consent Hypersensitivity to tetanus, diphtheria or pertussis immunizations






of 66





of 66

URINE SAMPLING MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may initiate the following directive for Urine R & M screening and/or beta HCG testing. Medical Directive Description: Urine specimens are to be collected and sent to the lab prior to patient assessment by an Emergency Physician when the specific conditions outlined below are present. Patient Description/Population: Patients with specific complaints of flank pain, abdominal pain, back pain, pelvic pain or discomfort, genitor-urinary symptoms and vaginal bleeding. Female patients of child bearing age without a previous history of a hysterectomy; with either the above complaints or anticipated to require Radiography will have a urine beta-HCG sent to the lab. Identify relevant Delegated Control Act or Added Skill associated with this Directive: The procedure is not a controlled act but falls with the plan of care. Specific conditions/circumstances that must be met before the Directive can be implemented: The patient must fall under one of the patient populations described above Contraindications to the implementation of the Directive:

Lack of patient or guardian consent

Patients obviously pregnant in the third trimester may have the beta-HCG waived

CTAS 1 patients require resuscitation first then the directive may be implemented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council Related Documents: References: Refer to appendix 1 The use of this Medical Directive must be documented on the Emergency Chart.




of 66

URINARY CATHETERIZATION MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses working in the Emergency Department may insert a urinary catheter for adult patients arriving to the Emergency Department prior to being assessed by the Emergency Physician Medical Directive Description: ● Insert a14-18 Foley Catheter (or consider a 20-22 three way foley for

suspected blood clot retention) ● Use a 2% Lidocaine jelly (Urojet) for male patients ● The catheter will be left in and document drainage amount and catheter

size.

Patient Description/Population: Adult patients 18 years of age or older Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented: Explanation of each of the above procedures must be provided to the patient. The patient must verbally consent to each of these procedures. The patient presents with ● A history of self catheterization and is requesting one be inserted ● Urinary retention or gross hematuria with clots ● Pulmonary Edema (for output measurement and symptomatic relief of bedpan

use) ● Multiple trauma (but no blood in urethral meatus or signs of GU trauma) Contraindications to the implementation of the Directive: ● Lack of patient consent. ● Allergy to Lidocaine (do not use urojet) or latex (use latex free

materials) ● Stop if resistance is encountered Documentation requirements:


Response to medications administered must be documented Review/Evaluation Process (how often/by who): every 2 years Corporate ER Council



of 66

Related Documents: References: Refer to appendix 1





of 66

WRIST AND SCAPHOID X-RAYS MEDICAL DIRECTIVE

Authorized to who: Appropriately educated Registered Nurses who are working in the Emergency Department may initiate the following therapies for any adult patients who present with symptoms of a fractured Wrist. Bony tenderness must be established. Medical Directive Description:

Establish baseline vital signs (B/P, P, R, O2 Sat)





Assess patient pain must be present over the distal radius and ulna and/or the carpal bones for a wrist x-ray

If tenderness is elicited over the anatomical “snuff box” or over the scaphoid tubercle add Scaphoid views to the wrist x-ray views.

Patient Description/Population: Patient must present with pain suggestive of a fractured wrist on initial assessment by nurse. Affected wrist may be swollen and painful on examination. A history of significant injury or trauma must be present.

Patient must be 18 years of age or older and not pregnant. Identify relevant Delegated Control Act or Added Skill associated with this Directive: Specific conditions/circumstances that must be met before the Directive can be implemented: Each intervention will be explained to the patient and/or family and verbal consent will be obtained.










of 66







of 66

LIST OF AUTHORIZING PHYSICIANS: LAKERIDGE HEALTH OSHAWA

Physician’s Name Signature Date

Dr. P. Blecher ________________________________ ________________

Dr. T. Chin _________________________________ ________________

Dr. F. Fung _________________________________ ________________

Dr. K. Green _________________________________ ________________

Dr. L. Irish _________________________________ ________________

Dr. P. Moran _________________________________ ________________

Dr. F. Moss _________________________________ ________________

Dr. T. Novak _________________________________ ________________

Dr. E. Paidra _________________________________ ________________

Dr. J. Shipley _________________________________ ________________

Dr. N. Stein _________________________________ ________________

Dr. R. Stuparyk _________________________________ ________________

Dr. R. Vandersluis _________________________________ ________________

Dr. C. Walker _________________________________ ________________

Dr. S. Whittaker _________________________________ ________________



of 66

LIST OF AUTHORIZING PHYSICIANS: LAKERIDGE HEALTH BOWMANVILLE

Physician’s Name Signature

Date

Dr. M. Albert ___N/A___________________________ ________________

Dr. H. Burke _________________________________ ________________

Dr. V. Dubey _________________________________ ________________

Dr. L. Durante _________________________________ ________________

Dr. S. Finlay _________________________________ ________________

Dr. B. Fuller _________________________________ ________________

Dr. V. Ho _________________________________ ________________

Dr. A. Hollander _________________________________ ________________

Dr. L. Irish _________________________________ ________________

Dr. D. Jefferson _________________________________ ________________

Dr. A. Kassirer _________________________________ ________________

Dr. S. Kim _________________________________ ________________

Dr. T. Kiran _________________________________ ________________

Dr. C. Lennox _________________________________ ________________

Dr. R. Lombardi _________________________________ ________________

Dr. W. Lottering _________________________________ ________________

Dr. R. Moolla _________________________________ ________________

Dr. L. Nijmeh _________________________________ ________________

Dr. E. Osborne _________________________________ ________________

Dr. L. Salamon ___N/A___________________________ ________________

Dr. D. Shiu _________________________________ ________________

Dr. A. Stone _________________________________ ________________

Dr. H. Williams _________________________________ ________________



of 66

LIST OF AUTHORIZING PHYSICIANS: LAKERIDGE HEALTH PORT PERRY

Physician’s Name Signature Date

Dr. M. Adams ________________________________ ________________

Dr. F Ali _________________________________ ________________

Dr. M. Brown _________________________________ ________________

Dr. A. Dayal _________________________________ ________________

Dr. K. Ferguson _________________________________ ________________

Dr. M. Gilmour _________________________________ ________________

Dr. S. Hyshka _________________________________ ________________

Dr. N. Kazarian _________________________________ ________________

Dr. R. Lombardi _________________________________ ________________

Dr. G. Mercer _________________________________ ________________

Dr. S. Russell _________________________________ ________________

Dr. S. Shepherd _________________________________ ________________

Dr. K. Smith _________________________________ ________________

Dr. J. Tuck _________________________________ ________________



of 66

SIGNATURE LIST OF COMMITTEE AND PROGRAM APPROVALS (Chairs)

Approvals and Signatures

Name Position Signature Date

Dr. R. Vandersluis Chief ____________________________ _________

Dr. B. Fuller Physician

Leader

____________________________ _________

Ms. M. Tink Program

Leader

____________________________ _________

Mr. T. Sellers Clinical

Educator

____________________________ _________

Program Committee/Council LHC ER Council _________

Mr. T. Chambers

Chair of CHPC

or PPC

____________________________

_________

Dr. J. Eisenstaat Chair of P & T ____________________________ _________

Final Approval:

Dr. D. Atkinson

Chair, MAC

____________________________

_________



of 66

REVIEW AND APPROVAL TRACKING FORM

Delegated Controlled Act / Medical Directive / Routine Order

Document Title: LHC Emergency Department Medical Directives – see attached listing

Contact Person:

(name of key physician or health professional)

Dr R Vandersluis

Sponsored by:

(Program/Discipline)

LHC Emergency Program

Reviewed by Stakeholders: Please check

or type N/A Date Reviewed

Peer Program(s) Medical Program Respiratory Therapy

√ November 2004

Medication Committee √ May 2005

Laboratory Council √ January 2005

Diagnostic Imaging Council √ January 2005

Infection Control n/a

P & T Committee √ May 2005

Profession Leader(s) √ May 2005

Other stakeholders (identify) Paediatrician

√ May 2005

Recommended by: Please check or type N/A Date Approved

Program/Discipline Council

Corporate Nursing Practice Council √ May 2005

Professional Practice Council √ May 2005

FINAL APPROVAL

Medical Advisory Committee

√ October 2005

References used in the development:

TO BE COMPLETED BY CORPORATE MEDICAL STAFF OFFICE:

Posted Electronic:

Communication:



of 66

MEDICAL DIRECTIVE APPENDIX 1 REFERENCES

Informed Plus Document #9103 – Institute for Clinical Evaluative Sciences (ICES) Canadian Asthma Consensus Report – Canadian Medical Association Journal 1999; 161:S1-S12. McKenzie, N. (1998). Upping the body’s thermostat. Learn how to maneuver the peaks, valleys of body temperature. Nursing 98, October. p. 41-45. Compendium of Pharmaceuticals and Specialties. (2004). Dosing chart for acetaminophen. p. 18. Compendium of Pharmaceuticals and Specialties. (2004). Dosing chart for Ibuprofen. P. 1258. Rourke, K. (2003). An orthopedic nurse practitioner’s practical guide to evaluating knee injuries. Journal of Emergency Nursing, 29(4). p. 366-372. Barry, M.E. (2001). Ankle sprains: Prompt and accurate diagnosis is critical to proper healing. American Journal of Nursing, 101(10). p. 40-42. Larsen, D. (2002). Assessment and management of foot and ankle fractures. Nursing Standard. 17(6). p. 37-48. Institute for Clinical Evaluative Sciences. (nk). Ottawa ankle rules- Physician information. p. 1-2. Stiell, I.G., McKnight, R.D., Greenberg, G.H., et al. (1994). Implementation of the Ottawa ankle rules. Journal of American Medical Association. 271. p. 827-832.

Institute for Clinical Evaluative Sciences. (1994). Twist and shout: deciding when to x-ray a sprained ankle. Informed Newsletter, 1(1). p. 1-2. McGraw, R.C., & Miller, M. (1998). Chest pain in the ER: The new serum markers. Patient Care Canada, 9(10) p. 33-35. Lazzara, D., & Sellergren, C. (1996). Chest pain. Making the right call when pressure is on. Nursing 96, November p. 42-51. Wood, D.G. (2001). Rapid assessment of chest pain: The rationale is clear, but evidence is needed. British Medical Journal, 323(7313). p. 586-587. Substance Abuse and Toxicoloical Emergencies – Rouge Valley Centenary Advance Triage Learning Package Emergency Nurses Association. (2003). Sheehy’s emergency nursing: Principals and practices. 5

th

Edition. Mosby: Philadelphia. Kidd, P.S., Sturt, P.A., & Fultz, J. (2000). Emergency nursing reference. 2

nd Edition. Mosby: Philadelphia.

Perry, A.G., & Potter, P.A. (2002). Clinical nursing skills and techniques. 5

th Edition. Mosby: St.Louis.

Orthopedic Trauma and Musculoskeletal System Assessment – Rouge Valley Centenary Advanced Triage. Hanson, M.J.S. (1997). Caring for a patient with COPD. Nursing 97, December. p. 39-44. Whatling, J. (1995). Managing chronic obstructive disease. Nursing Standard, 10(8). p. 34-37.



of 66

Informed Plus – Document # 8231 ICES 2002 Institute for Clinical Evaluative Sciences. (1998). The (k) need for x-rays. The Ottawa knee rule- x-rays in acute knee injuries. Informed Newsletter, 4(3). p. 1-3. Rourke, K. (2003). An orthopedic nurse practitioner’s practical guide to evaluating knee injuries. Journal of Emergency Nursing, 29(4). p. 366-372 Hooper, M. (1997). Prompt treatment for chemical eye injuries. Nursing Standard, 11(36). p. 40-43. CHN Emergency Medical Directives for Children Draft #2 – August 2002 Asthma Management Guidelines – The Hospital for Sick Children Drug Formulary CPS 2004 Fever dosing charts, p. 18, 1258 CHN Emergency Medical Directives for Children – Draft #2 – August 2002 Compendium of Pharmaceuticals and Specialties. (2004). Dosing chart for acetaminophen. p. 18. Compendium of Pharmaceuticals and Specialties. (2004). Dosing chart for Ibuprofen. P. 1258. Weeks, S.M. (1996). Caring for patients with heart failure. Nursing 96 March p. 52-53. Informed Plus – Document # 8120 ICES 2001 Goshorn, J. (NK). Kidney stones. Strategies for managing this common, excruciating condition. Clinical Snapshot. p. 1-2. Jelinek, G. (2000). Ketorolac versus morphine for severe pain: Ketorolac is more effective, cheaper, and has fewer side effects. British Medical Journal, 321(7272). p. 1236-1237. Wright, P. J., Hurgin, A.P.S., & Marsden, S.N.E. (2002). Managing acute renal colic across the primary-secondary care interface: A pathway of care based in evidence and consensus. British Medical Journal, 325(7377). p. 1408-1412. Hooper, M. (1997). Prompt treatment for chemical eye injuries. Nursing Standard, 11(36). p. 40-43. Kidd, P.S., Sturt, P.A., & Fultz, J. (2000). Emergency nursing reference. 2


Emergency Nurses Association. (2003). Sheehy’s emergency nursing: Principals and practices. 5

th

Edition. Mosby: Philadelphia. McGraw, R.C., & Miller, M. (1998). Chest pain in the ER: The new serum markers. Patient Care Canada, 9(10) p. 33-35. Lazzara, D., & Sellergren, C. (1996). Chest pain. Making the right call when pressure is on. Nursing 96, November p. 42-51. Weeks, S.M. (1996). Caring for patients with heart failure. Nursing 96 March p. 52-53. Institute for clinical Evaluative Sciences. (1997). Breathing easier. A new asthma continuum facilitates the diagnosis and treatment of asthma. Informed Newsletter 3(4) p. 1-5. Hanson, M.J.S. (1997). Caring for a patient with COPD. Nursing 97, December. p. 39-44.



of 66

Reising, D.L. (1995). Acute hypoglycemia. Keeping the bottom from falling out. Nursing 95, February. p. 41-48. McKenzie, N. (1998). Upping the body’s thermostat. Learn how to maneuver the peaks, valleys of body temperature. Nursing 98, October. p. 41-45. Cain, M. 91998). Treating pediatric fever: Helpful or harmful? Patient Care Canada, 9(10). p. 13. McNew, C.D., Hunt, S., & Warner, L.S. (1997). How to help your patient with epilepsy. Nursing 97. September. p. 57-62. Smith, R. (1997). Diagnosing headache. Hospital Medicine. July. p. 26-42. Goshorn, J. (NK). Kidney stones. Strategies for managing this common, excruciating condition. Clinical Snapshot. p. 1-2. Peden, A.C. (1996). Action stat. Ruptured ectopic pregnancy. Nursing 96, May. p. 33. Lerner-Durjava, L. (1996). Combating infection. Protecting against tetanus. Nursing 96, February. p. 26-27. Institute for Clinical Evaluative Sciences. (1998). The (k) need for x-rays. The Ottawa knee rule- x-rays in acute knee injuries. Informed Newsletter, 4(3). p. 1-3. Institute for Clinical Evaluative Sciences. (1994). Twist and shout: deciding when to x-ray a sprained ankle. Informed Newsletter, 1(1). p. 1-2. Institute for Clinical Evaluative Sciences. (nk). Ottawa ankle rules- Physician information. p. 1-2. Kidd, P.S., Sturt, P.A., & Fultz, J. (2000). Emergency nursing reference. 2


Emergency Nurses Association. (2003). Sheehy’s emergency nursing: Principals and practices. 5

th

Edition. Mosby: Philadelphia. Lakeridge Health Oshawa/Whitby Pharmacy- IV Monographs. Accessed April 8, 2005. Kaniecki, R. (2003). Headache assessment and management. The Journal of the American Medical Association, 289(11). p. 1430-1433. Canadian Asthma Consensus report. (1999). Diagnosis and evaluation of asthma in adults. Canadian Medical Association Journal, 161(11). p. 56-57. Wright, J. (1997). Seven abdominal assessment signs every emergency nurses should know. Journal of Emergency Nursing, 23(5). p. 446-450. Perry, A.G., & Potter, P.A. (2002). Clinical nursing skills and techniques. 5

th Edition. Mosby: St.Louis.

Stiell, I.G., McKnight, R.D., Greenberg, G.H., et al. (1994). Implementation of the Ottawa ankle rules. Journal of American Medical Association. 271. p. 827-832. Compendium of Pharmaceuticals and Specialties. (2004). Dosing chart for acetaminophen. p. 18. Compendium of Pharmaceuticals and Specialties. (2004). Dosing chart for Ibuprofen. P. 1258. Informed Plus Document #9103 – Institute for Clinical Evaluative Sciences (ICES). (1999). Canadian Asthma Consensus Report – Canadian Medical Association Journal, 161. p. S1-S12.



of 66

Whatling, J. (1995). Managing chronic obstructive disease. Nursing Standard, 10(8). p. 34-37. Wood, D.G. (2001). Rapid assessment of chest pain: The rationale is clear, but evidence is needed. British Medical Journal, 323(7313). p. 586-587. Wright, P. J., Hurgin, A.P.S., & Marsden, S.N.E. (2002). Managing acute renal colic across the primary-secondary care interface: A pathway of care based in evidence and consensus. British Medical Journal, 325(7377). p. 1408-1412. Jelinek, G. (2000). Ketorolac versus morphine for severe pain: Ketorolac is more effective, cheaper, and has fewer side effects. British Medical Journal, 321(7272). p. 1236-1237. Rourke, K. (2003). An orthopedic nurse practitioner’s practical guide to evaluating knee injuries. Journal of Emergency Nursing, 29(4). p. 366-372. Barry, M.E. (2001). Ankle sprains: Prompt and accurate diagnosis is critical to proper healing. American Journal of Nursing, 101(10). p. 40-42. Larsen, D. (2002). Assessment and management of foot and ankle fractures. Nursing Standard. 17(6). p. 37-48. Hooper, M. (1997). Prompt treatment for chemical eye injuries. Nursing Standard, 11(36). p. 40-43. Child Health Network. (2002). Medical directives for children. Draft #2. August. Orthopedic Trauma and Musculoskeletal System Assessment – Rouge Valley Centenary Advanced Triage. Ottawa Ankle Rules – Dr. I. Stiell et.al. ICES. 1993. Substance Abuse and Toxicological emergencies – Rouge Valley Centenary Advance Triage Learning Package. Informed Plus- Document # 8231. ICES 2002. Asthma Management Guidelines- The Hospital for Sick Children Drug Formulary. Government of Ontario. (nk). Emergency guidelines for managing the child with type 1 diabetes. Compendium of Pharmaceuticals and Specialties (2004). Drug Monographs. Pgs. 2153, 204, 47, 16, 1340, 185, 412, 462, 684, 14, 960, 1074. Canadian Immunization Guide Edition 6 http://www.phac-aspc.gc.ca/publicat/cig-gci/pdf/cdn_immuniz_guide-2002-6.pdf Canadian Diabetes Association 2003 Clinical Practice Guidleines http://www.diabetes.ca/cpg2003/chapters.aspx?periacutecoronarysyndromeglycemiccontrol.htm Rainbow J. et al (2002) Controlling seizures in the prehospital setting: diazepam or midazolam, J Pedaitr Child Health, Dec;38(6): 582-6 Fisgin T, et al (2002) Effects of intranasal midazolam and rectal diazepam in acute consulsions in children: prospective randomized study, J Child Neurol. 2002 Feb;17(2): 123-6 Classen J. etal (2002) Treatment of refractory status epilepticus with pentobarbital,propofol or midazolam: a systematic review. Epilepsia. 2002 Feb;43(2):146-53

http://www.phac-aspc.gc.ca/publicat/cig-gci/pdf/cdn_immuniz_guide-2002-6.pdf

http://www.phac-aspc.gc.ca/publicat/cig-gci/pdf/cdn_immuniz_guide-2002-6.pdf

http://www.diabetes.ca/cpg2003/chapters.aspx?periacutecoronarysyndromeglycemiccontrol.htm



of 66

Harbord MG etal (2004) Use of intranasal midazolam to treat seizures in pediatric community settings, J Pediatr Child Health. 2004 Sept-Oct;40(9-10):556-8 Yoshikawa H etal (2000) Midazolam as a first line agent for status epilepticus in children, Brain Dev. 2000 Jun;22(4):239-42 Towne AR etal (1999) Use of intramuscular midazolam for status epilepticus. J Emerg Med. 1999 Mar-Apr;17(2):323-8 Scott RC etal (1999) Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet. 1999 Feb 20;353(9153):623-6 Pellock JM (1998) Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol. 1998 Dec;13(12):581-7 Yakinci C etal (1997) Midazolam in treatment of various types of seizures in children, Brain Dev. 1997 Dec;19(8):571-2

Lakeridge Health CorporationLakeridge Health Corporation Emergency Medical Directives - 2005 Page 4...

Documents

Transcript of Lakeridge Health CorporationLakeridge Health Corporation Emergency Medical Directives - 2005 Page 4...